All news (page 20)

31 August 2026

KBR advances Woodside Pluto Train 1 modifications

Upgrades will let the Train 1 facility process up to 3 Mtpa of Scarborough gas; scope includes an NGL unit, nitrogen recycle compressor and custody metering; major module lift and a 4,600 t module installed.
31 August 2026

Veloxis doses first patient in Phase 2 RENGEVITY-201 of pegrizeprument (VEL-101)

Phase 2 trial compares pegrizeprument with tacrolimus in up to 120 de novo kidney transplant recipients; primary endpoints are safety, pharmacokinetics and pharmacodynamics.
31 August 2026

MAIRE (Tecnimont) wins ICC Phase 1 award finding EuroChem’s K2 termination wrongful

London tribunal upholds suspension due to sanctions, orders ~€260m to Tecnimont, rejects €1.6bn counterclaims; Phase 2 will consider injunctions and extra damages.
31 August 2026

Uniper advances NorthStarH2 into FEED with AFRY, Carbon Clean, Siemens Energy and Topsoe

Contracts worth >SEK100m launch ~1-year FEED for a 115,000 t/yr e‑methanol plant using renewable electricity and biogenic CO2; FID 2028, commissioning 2031.
31 August 2026

Topsoe to deliver FEED for Uniper's NorthStarH2 e‑methanol project

115,000 t/y e‑methanol plant in Östersund using modular ModuLite tech; FID targeted 2028; will combine renewable hydrogen with biogenic CO₂ and use existing road/rail logistics.
31 August 2026

Axens chosen by Expander Energy for FT liquids upgrading to produce 2G drop-in biofuels

FT liquids upgrading tech to convert cellulosic feedstock into drop-in SAF and renewable diesel; initial deployment at two Canadian facilities; FID targeted December 2026.
31 August 2026

Amgen: Repatha reduces all‑cause mortality in high‑risk primary prevention (VESALIUS‑CV)

Pre‑specified VESALIUS‑CV analysis shows evolocumab plus background therapy lowers deaths and major CV events in high‑risk adults without prior MI/stroke.
31 August 2026

AGC Glass Europe and Saint‑Gobain launch hybrid furnace project

Hybrid furnace to cut CO₂ from flat glass production; construction starts Jan 2027, production H2 2027; co-funded by the EU ETS Innovation Fund.
31 August 2026

Sinopec signs strategic MoU with Algeria National Oil Company

MoU outlines cooperation on conventional and unconventional oil and gas exploration, engineering services and equipment manufacturing after a high-level meeting.
31 August 2026

Ørsted and Nuveen: Borkum Riffgrund 3 enters commercial operation

913 MW offshore wind farm now operational; 83 turbines and 786 MW of corporate PPAs will supply industry and households, boosting Germany's domestic renewable capacity.
31 August 2026

AkzoNobel and Axalta appoint three non-executive directors to combined Board

Stephan B. Tanda, Denise C. Johnson and Robert Schuchna will join as non-executive directors; appointments to be voted at an Extraordinary General Meeting later this year.
30 August 2026

Toray launches two nanofiltration membrane elements

Two nanofiltration elements launched in July 2026: one chemically durable for industrial wastewater and MLD/ZLD, the other low‑pressure with high PFAS removal and high permeate flow.
29 August 2026

SONATRACH and Anton Oilfield Services sign MoU on unconventional resources and EOR

MoU to evaluate cooperation on unconventional resources, marginal deposits, EOR, local completion tool manufacture and technology transfer.
29 August 2026

Eni named operator of Uruguay OFF-5 and agrees 40% stake in OFF-6

Enters OFF-5 as operator with 50% interest alongside MIWEN; OFF-5 in first exploration period with studies under way; agreed 40% interest in adjacent OFF-6.
28 August 2026

SCG Chemicals, Earthology & Jim Thompson unveil ReNylon x ReSilk hybrid fabric

Prototype merges recycled fishing-net nylon with silk production waste to boost durability and retain luster; Nets Up has recovered 80+ tonnes of nets, cutting ~450 kgCO₂eq.
28 August 2026

Takeda: FDA approves MIMRYLO (rusfertide) for erythrocytosis in polycythemia vera

First-in-class hepcidin mimetic approved for adult PV erythrocytosis; Phase 3 VERIFY showed hematocrit control, reduced phlebotomy and improved fatigue.
28 August 2026

Eli Lilly’s Mounjaro approved by FDA to reduce cardiovascular risk in adults with type 2 diabetes

First GIP+GLP‑1 agonist authorised to lower major adverse cardiovascular events in high‑risk adults with type 2 diabetes; SURPASS‑CVOT enrolled >13,000 with ~4‑year median follow‑up.
28 August 2026

Roche: Vabysmo shows two‑year efficacy and extended dosing in PCV (SALWEEN)

Dual Ang‑2/VEGF‑A inhibitor delivered vision gains, lesion regression and dosing intervals up to 20 weeks for most patients in a two‑year Asian PCV trial.
28 August 2026

Wanhua Chemical shifts into new energy and battery materials

Designates battery materials as its second core business; secures phosphorus and lithium upstream; opened Haiyang Green Power Industrial Park for LFP production in March 2025; broadened downstream battery-materials portfolio.
28 August 2026

PETRONAS 1H 2026: resilient results and energy-security focus

Revenue up 15% to RM152.4bn; PAT RM27.2bn; CAPEX RM41.4bn and full ownership of PRefChem expected in 2H 2026 amid West Asia conflict-driven volatility.
28 August 2026

OMV Petrom raises Petrobrazi green hydrogen capacity to 55 MW with second 35 MW electrolyzer

Second 35 MW electrolyzer fully delivered, lifting Petrobrazi’s green H2 capacity to 55 MW to supply refining and a 250,000 t/y SAF/HVO unit.
27 August 2026

ANDRITZ doubles turbogenerator production capacity at Linz plant

700 m² hall added; site now assembles hydrogen-cooled units and can ship generators up to 300 t via the Danube; further 3,000 m² refit due 2028.
27 August 2026

AFYREN advances NEOXY ramp-up and validates its biobased model

Plant passed 1,000 t of bio-based acids; capacity reached 30–40% after June works; process held up during heat/water stress; aims to double NEOXY H2 2026 revenue vs H1.
27 August 2026

Syensqo: USITC ALJ finds infringement of PVDF patent

An Administrative Law Judge found rival PVDF products infringe a patent covering PVDF used in lithium‑ion batteries; the ruling is preliminary and subject to review and appeal.
27 August 2026

Formosa Smart Energy: CH Algae secures ISCC EU for algae oil, broadens SAF feedstocks

Algae oil gains ISCC EU certification; pilot 500‑L line meets SAF feedstock specs with 50–60% oil content; company plans scale‑up to demonstration and commercial production.
27 August 2026

Metso selected as process technology partner for New Simberi expansion

EUR 10m order booked; deliveries include Vertimill regrind, TankCell flotation, VPA pressure filtration and HRT thickener to enable sulphide processing and ~200,000 oz/year target.
27 August 2026

TotalEnergies completes transfer of 10% Arctic LNG 2 stake to Novatek subsidiary

Transfer of a 10% Arctic LNG 2 stake to NordLine completed; TotalEnergies retains claim for about US$1.3bn in shareholder loans, subject to sanctions.
27 August 2026

Evonik expands LNP GMP manufacturing with new Vancouver facility

New plant adds clinical-scale lipid nanoparticle drug product capacity with federal support; production is planned to start at the end of 2029.
27 August 2026

Ammobia and Lummus to commercialize modular low‑capex ammonia (Haber‑Bosch 2.0)

Partnership to deploy a lower‑temperature, lower‑pressure modular ammonia process via established engineering and project delivery to serve maritime fuel, energy storage and power markets.
27 August 2026

argenx acquires Forte Biosciences, adds anti‑CD122 antibody FB102

Adds FB102, a first‑in‑class anti‑CD122 with clinical proof‑of‑concept in vitiligo and celiac disease; $77 per‑share tender offer completed and merger closed.

← Previous Next →